which significantly impact ovarian cancer treatment. New drugs like PARP inhibitors are used in patients with BRCA mutations, improving survival rates by inhibiting the DNA repair in cancer cells ...

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition to develop breast cancer, ovarian, prostate, pancreatic ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Individuals who transition from overweight to obese during adulthood may face a higher ovarian cancer risk, highlighting the ...

A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancers origins within the body as well as insights into new treatment strategies for Ovarian cancer.